{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:56:21Z","timestamp":1740149781177,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T00:00:00Z","timestamp":1564185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T00:00:00Z","timestamp":1564185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12328-019-01028-z","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T06:02:21Z","timestamp":1564207341000},"page":"17-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case of esophageal cancer with human immunodeficiency virus infection that progressed rapidly after neoadjuvant chemoradiotherapy"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-6794","authenticated-orcid":false,"given":"Yuka","family":"Hayakawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumasa","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mana","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahito","family":"Nozaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitsugu","family":"Misumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuki","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Furumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,27]]},"reference":[{"key":"1028_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/QAD.0b013e3282f47082","volume":"22","author":"JL Long","year":"2008","unstructured":"Long JL, Engels EA, Moore RD, et al. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS. 2008;22:489\u201396.","journal-title":"AIDS."},{"key":"1028_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1245\/s10434-011-2049-9","volume":"19","author":"N Ando","year":"2012","unstructured":"Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68\u201374.","journal-title":"Ann Surg Oncol"},{"key":"1028_CR3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ijrobp.2010.06.033","volume":"81","author":"K Kato","year":"2011","unstructured":"Kato K, Muro K, Minashi K, et al. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys. 2011;81:684\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1028_CR4","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1097\/QAD.0000000000001077","volume":"30","author":"EL Yanik","year":"2016","unstructured":"Yanik EL, Katki HA, Engels EA. Cancer risk among the HIV-infected elderly in the United States. AIDS. 2016;30:1663\u20138.","journal-title":"AIDS."},{"key":"1028_CR5","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1200\/JCO.2013.54.8644","volume":"32","author":"G Suneja","year":"2014","unstructured":"Suneja G, Shiels MS, Angulo R, et al. Cancer treatment disparities in HIV-infected individuals in the United States. J Clin Oncol. 2014;32:2344\u201350.","journal-title":"J Clin Oncol"},{"key":"1028_CR6","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.jss.2011.10.006","volume":"174","author":"XJ Xia","year":"2012","unstructured":"Xia XJ, Liu BC, Su JS, et al. Preoperative CD4 count or CD4\/CD8 ratio as a useful indicator for postoperative sepsis in HIV-infected patients undergoing abdominal operations. J Surg Res. 2012;174:e25\u201330.","journal-title":"J Surg Res"},{"key":"1028_CR7","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1001\/archsurg.133.6.626","volume":"133","author":"RG Albaran","year":"1998","unstructured":"Albaran RG, Webber J, Steffes CP. CD4 cell counts as a prognostic factor of major abdominal surgery in patients infected with the human immunodeficiency virus. Arch Surg. 1998;133:626\u201331.","journal-title":"Arch Surg"},{"key":"1028_CR8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s00268-013-1915-y","volume":"37","author":"J Su","year":"2013","unstructured":"Su J, Tsun A, Zhang L, et al. Preoperative risk factors influencing the incidence of postoperative sepsis in human immunodeficiency virus-infected patients: a retrospective cohort study. World J Surg. 2013;37:774\u20139.","journal-title":"World J Surg"},{"key":"1028_CR9","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1200\/JCO.2008.16.8252","volume":"26","author":"JP Spano","year":"2008","unstructured":"Spano JP, Costagliola D, Katlama C, et al. AIDS-related malignancies: state of the art and therapeutic challenges. J Clin Oncol. 2008;26:4834\u201342.","journal-title":"J Clin Oncol"},{"key":"1028_CR10","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1097\/00002030-200108170-00005","volume":"15","author":"A Antinori","year":"2001","unstructured":"Antinori A, Clingolani A, Alba L, et al. Better response to chemotherapy and prolonged survival therapy in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS. 2001;15:1483\u201391.","journal-title":"AIDS."},{"key":"1028_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.lungcan.2008.11.018","volume":"65","author":"A Lavole","year":"2009","unstructured":"Lavole A, Chouaid C, Baudrin L, et al. Effect of highly active antiretroviral therapy on survival of HIV-infected patients with non-small-cell lung cancer. Lung Cancer. 2009;65:345\u201350.","journal-title":"Lung Cancer."},{"key":"1028_CR12","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1080\/1042819021000006402","volume":"43","author":"JT Navarro","year":"2002","unstructured":"Navarro JT, Ribera JM, Oriol A, et al. Favorable impact of virological response to highly active antiretroviral therapy on survival in patients with AIDS-related lymphoma. Leuk Lymphoma. 2002;43:1837\u201342.","journal-title":"Leuk Lymphoma"},{"key":"1028_CR13","first-page":"805","volume":"72","author":"J Molt\u00f3","year":"2017","unstructured":"Molt\u00f3 J, Rajoli R, Back D, et al. Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs. J Antimicrob Chemother. 2017;72:805\u201311.","journal-title":"J Antimicrob Chemother"},{"key":"1028_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2174\/157016210791111061","volume":"8","author":"M Berretta","year":"2010","unstructured":"Berretta M, Lleshi A, Cappellani A, et al. Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection. Curr HIV Res. 2010;8:218\u201322.","journal-title":"Curr HIV Res"},{"key":"1028_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijsu.2016.08.520","volume":"34","author":"BP Phakathi","year":"2016","unstructured":"Phakathi BP, Basson G, Karusseit VOL, et al. The effect of HIV infection on the surgical, chemo- and radiotherapy management of breast cancer. A prospective cohort study. Int J Surg. 2016;34:109\u201315.","journal-title":"Int J Surg."},{"key":"1028_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1179\/joc.2007.19.3.343","volume":"19","author":"M Berretta","year":"2007","unstructured":"Berretta M, Martellotta F, Simonelli C, et al. Cetuximab\/targeted chemotherapy in an HIV-positive patient with metastatic colorectal cancer in the HAART era: a case report. J Chemother. 2007;19:343\u20136.","journal-title":"J Chemother"},{"key":"1028_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1269\/jrr.10090","volume":"51","author":"T Kaminura","year":"2010","unstructured":"Kaminura T, Karasawa K, Hanyu N, et al. Acute advance effects of radiation therapy on HIV-positive patients in Japan: study of 31 cases at Tokyo Metropolitan Komagome Hospital. J Radiat Res. 2010;51:749\u201353.","journal-title":"J Radiat Res."},{"key":"1028_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.radonc.2010.11.011","volume":"98","author":"I Fraunholz","year":"2011","unstructured":"Fraunholz I, Rabeneck D, Gerstein J, et al. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: are there difference between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy? Radiother Oncol. 2011;98:99\u2013104.","journal-title":"Radiother Oncol"},{"key":"1028_CR19","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1200\/JCO.2007.15.2348","volume":"26","author":"C Oehler-J\u00e4nn","year":"2008","unstructured":"Oehler-J\u00e4nn C, Huguet F, Provencher S, et al. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy. J Clin Oncol. 2008;26:2550\u20137.","journal-title":"J Clin Oncol"},{"key":"1028_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/DCR.0000000000000057","volume":"57","author":"IB Fraunholz","year":"2014","unstructured":"Fraunholz IB, Haberl A, Klauke S, et al. Long-term effects of chemoradiotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV disease. Dis Colon Rectum. 2014;57:423\u201331.","journal-title":"Dis Colon Rectum"},{"key":"1028_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10350-007-9154-7","volume":"51","author":"A Wexler","year":"2008","unstructured":"Wexler A, Berson AM, Goldstone SE, et al. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum. 2008;51:73\u201381.","journal-title":"Dis Colon Rectum"},{"key":"1028_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/QAD.0000000000000071","volume":"28","author":"PG Rubinstein","year":"2014","unstructured":"Rubinstein PG, Aboulafia DM, Zloza A. Malignancies in HIV\/AIDS: from epidemiology to therapeutic challenges. AIDS. 2014;28:453\u201365.","journal-title":"AIDS."},{"key":"1028_CR23","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1182\/blood.V87.3.919.bloodjournal873919","volume":"87","author":"AV Moses","year":"1996","unstructured":"Moses AV, Williams S, Heneveld ML, et al. Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood. 1996;87:919\u201325.","journal-title":"Blood"},{"key":"1028_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/cid\/ciu174","volume":"59","author":"HA Torres","year":"2014","unstructured":"Torres HA, Mulanovich V. Management of HIV infection in patients with cancer receiving chemotherapy. Clin Infect Dis. 2014;59:106\u201314.","journal-title":"Clin Infect Dis"},{"key":"1028_CR25","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S1470-2045(11)70056-0","volume":"12","author":"MA Rudek","year":"2011","unstructured":"Rudek MA, Flexner C, Ambinder RF. Use of antineoplastic agents in patients with cancer who have HIV\/AIDS. Lancet Oncol. 2011;12:905\u201312.","journal-title":"Lancet Oncol."}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-019-01028-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-019-01028-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-019-01028-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T23:32:58Z","timestamp":1595719978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-019-01028-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,27]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1028"],"URL":"https:\/\/doi.org\/10.1007\/s12328-019-01028-z","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2019,7,27]]},"assertion":[{"value":"26 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest in association with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures followed were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human\/animal rights"}},{"value":"Informed consent was obtained from the patient prior to treatment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}